AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2017
Mar 21, 2017
35221_dirs_2017-03-21_c4adbe1f-1d4d-4503-8fb8-b7a060027749.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2017-03-20
Reporting Person: MCGRATH DENNIS M (EVP & CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-20 | Employee Stock Option (Right to Buy) | $5.95 | A | 250000 | Acquired | 2027-03-19 | Common Stock (250000) | Direct |
Footnotes
F1: The option vests in 12 equal quarterly installments on the last day of each fiscal quarter, commencing on June 30, 2017.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23